Article
CFTR modulator monotherapy for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
The Cochrane database of systematic reviews - 7 May 2026
Heneghan Matthew, Smith Sherie, Jahnke Nikki, Nevitt Sarah, Southern Kevin W
Abstract excerpt
RATIONALE: Cystic fibrosis (CF) is a common, life-shortening genetic condition caused by a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. A class II CFTR gene variant, F508del, is the commonest CF-causing variant (found in up to 90% of people with CF (pwCF) in some populations). The F508del variant lacks meaningful CFTR function: the faulty protein is degraded before reaching...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
